已收盘 07-02 16:00:00 美东时间
-0.820
-1.17%
B of A Securities analyst Kevin Fischbeck maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $66 to $77.
07-02 22:45
今日重点评级关注:Baird:维持Regenxbio"跑赢大市"评级,目标价从27美元升至32美元;古根海姆:维持Tenax Therapeutics"买入"评级,目标价从34美元升至40美元
06-23 13:48
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. BTIG raised the price target for Brightspring Health Services Inc (NASDAQ:BTSG) from $65 to $90. BTIG analyst ...
06-22 21:00
TD Cowen analyst Charles Rhyee maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $65 to $81.
06-18 22:24
今日重点评级关注:Ascendiant Capital:维持IGC Pharma"买入"评级,目标价从5.25美元升至5.5美元;Ascendiant Capital:维持Lucid Diagnostics"买入"评级,目标价从9美元升至9.25美元
06-09 11:33
今日重点评级关注:Ascendiant Capital:维持Genasys"买入"评级,目标价从5.5美元升至6美元;Citizens:维持Abivax"跑赢大市"评级,目标价从131美元升至187美元
06-03 11:17
Morgan Stanley analyst Erin Wright maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price target from $62 to $71.
06-02 23:13
https://www.cms.gov/newsroom/press-releases/cms-announces-aggressive-nationwide-crackdown-fraud-six-month-hospice-home-health-agency-enrollment
05-13 21:03
今日重点评级关注:Citizens:维持Avalo Therapeutics"跑赢大市"评级,目标价从52美元升至62美元;BTIG:维持Avalo Therapeutics"买入"评级,目标价从40美元升至58美元
05-07 12:37
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从28美元升至49美元;HC Wainwright & Co.:维持Fate Therapeutics"买入"评级,目标价从5美元升至7美元
05-05 11:40